Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
基本信息
- 批准号:7587430
- 负责人:
- 金额:$ 34.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAffectAnimalsAntigen-Presenting CellsAntigensAntiviral AgentsBiological AssayCD28 AntigensCD28 geneCD8B1 geneCellsCharacteristicsChemotactic FactorsComplementComplement 5aDataDendritic CellsDevelopmentDiphtheria ToxinDoctor of MedicineDoctor of PhilosophyGenerationsGoalsITGAX geneImmuneImmune responseImmune systemImmunityInfectionInfluenzaInfluenza A virusLeadLungMHC Class I GenesMaintenanceMediatingMemoryMusNatural ImmunityPathway interactionsPeptidesPhasePlayRegulationReportingResearch PersonnelRoleSignal TransductionStagingStaining methodStainsT-LymphocyteTechnologyTimeTransgenic AnimalsVaccinesViralVirusVirus Diseasescytokinecytotoxiccytotoxicitydesignin vivoinfluenzavirusmigrationnovelnovel therapeuticspathogenreceptorresponsetherapeutic vaccinetumor
项目摘要
DESCRIPTION (provided by applicant): Recently it has become apparent that innate immunity can regulate aspects of the adaptive immune response. The aim of this proposal is to determine how dendritic cells (DC), cells of innate immunity, regulate cytotoxic CD8+ T cell responses to pathogens. To date much has been elucidated in terms of the role DC play during the initiation phase of adaptive immune responses. In particular these very potent antigen-presenting cells are critical for the initiation of antiviral CD8+ T cells responses. Mature DC expressing appropriate co-stimulation molecules are required to present antigen in order to initiate the activation of naive CD8+ T cells. What is not known, however, is whether DC play a role in the later expansion and contraction phases of the CD8+ T cell response. We have preliminary data showing that a great influx of DC occurs in the lungs of influenza type A virus infected animals 2-5 days postinfection and that costimulation is required during the later phases of the virus-specific CD8+ T cell response. By using DTR-CD11c transgenic animals we plan to deplete DC during different phases of the CD8+ T cell response and thus start to understand what role DC are playing during the later phases of CD8+ T cell response. The requirement of costimulation molecules such as CD28 or CD27 will also be investigated to delineate the mechanism of action of DC at these later stages of the response. Finally, the role of DC and whether costimulation is required in secondary CD8+ T cell responses is largely unknown. To date the classical costimulation pathway through CD28 has been extensively studied during the initiation phase of the immune response and found to be required for the maximal anti-viral CD8+ T cell response to take place. Its involvement in secondary responses is however not known even though some memory CD8+ T cells are known to express CD28. We will investigate the role of DC and the contribution of CD28 and CD27 in the secondary response and the generation of memory. In order to understand what the role of these DC is, we will investigate what are the characteristics of these pulmonary DC, whether they are infected, whether they present antigen and what cytokines they make. Finally, the mechanism that controls the migration of DC into the lungs will be investigated. The studies proposed here are novel as no previous study has examined how DC regulate expansion, contraction and the generation of memory during the later phases of the cytotoxic CD8+ T cell response. Elucidating the DC and costimulation requirements of cytotoxic CD8+ T cell responses may ultimately lead to the development of novel therapeutic and vaccine strategies against tumors and viral infections.
描述(由申请人提供):最近显然,先天免疫可以调节适应性免疫反应的各个方面。该建议的目的是确定树突状细胞(DC),先天免疫的细胞如何调节细胞毒性CD8+ T细胞对病原体的反应。迄今为止,在适应性免疫反应的开始阶段,DC的角色扮演的角色已被阐明了很多。特别是这些非常有效的抗原呈递细胞对于抗病毒CD8+ T细胞反应的启动至关重要。表达适当的共刺激分子的成熟直流需要呈现抗原,以启动幼稚的CD8+ T细胞的激活。但是,尚不清楚的是,直流是否在CD8+ T细胞反应的后来扩张和收缩阶段起作用。我们有初步数据表明,在感染后2-5天,在A型流感病毒感染动物的肺中大量涌入DC,并且在病毒特异性CD8+ T细胞反应的后期需要进行共刺激。通过使用DTR-CD11C转基因动物,我们计划在CD8+ T细胞响应的不同阶段耗尽DC,从而开始了解CD8+ T细胞反应的后期中DC在何种作用。还将研究诸如CD28或CD27之类的共刺激分子的需求,以描述在响应后期的这些后期阶段DC的作用机理。最后,DC的作用以及在次级CD8+ T细胞反应中是否需要进行共刺激的作用在很大程度上尚不清楚。迄今为止,在免疫反应的起始阶段已经对经典的CD28进行了经典的共刺激途径,并且发现最大抗病毒CD8+ T细胞反应需要进行。然而,即使已知某些记忆CD8+ T细胞表达CD28,它也不知道其参与次级响应。我们将研究DC的作用以及CD28和CD27在次级响应和记忆产生中的贡献。为了了解这些DC的作用是什么,我们将研究这些肺直流的特征是什么,它们是否被感染,它们是否存在抗原以及它们产生的细胞因子。最后,将研究控制直流向肺部迁移的机制。此处提出的研究是新颖的,因为先前没有研究如何调节细胞毒性CD8+ T细胞反应的后期中如何调节扩张,收缩和记忆产生。阐明细胞毒性CD8+ T细胞反应的直流和共刺激要求最终可能导致针对肿瘤和病毒感染的新型治疗和疫苗策略的发展。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections.
- DOI:10.4049/jimmunol.1501890
- 发表时间:2016-02-01
- 期刊:
- 影响因子:0
- 作者:Gracias DT;Boesteanu AC;Fraietta JA;Hope JL;Carey AJ;Mueller YM;Kawalekar OU;Fike AJ;June CH;Katsikis PD
- 通讯作者:Katsikis PD
Memory T cells need CD28 costimulation to remember.
- DOI:10.1016/j.smim.2009.02.005
- 发表时间:2009-04
- 期刊:
- 影响因子:7.8
- 作者:Boesteanu AC;Katsikis PD
- 通讯作者:Katsikis PD
CD28 and CD27 costimulation of CD8+ T cells: a story of survival.
CD8 T 细胞的 CD28 和 CD27 共刺激:生存的故事。
- DOI:10.1007/978-0-387-34814-8_11
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Dolfi,DouglasV;Katsikis,PeterD
- 通讯作者:Katsikis,PeterD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER D KATSIKIS其他文献
PETER D KATSIKIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER D KATSIKIS', 18)}}的其他基金
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
- 批准号:
8516438 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
- 批准号:
8695278 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
- 批准号:
8062112 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
- 批准号:
7884776 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Phosphorothioate Oligonucleotides as Microbicides against HIV Transmission
硫代磷酸酯寡核苷酸作为抗 HIV 传播的杀菌剂
- 批准号:
8482137 - 财政年份:2010
- 资助金额:
$ 34.88万 - 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
- 批准号:
6964213 - 财政年份:2005
- 资助金额:
$ 34.88万 - 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
- 批准号:
7084539 - 财政年份:2005
- 资助金额:
$ 34.88万 - 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
- 批准号:
7386756 - 财政年份:2005
- 资助金额:
$ 34.88万 - 项目类别:
Dendritic cell regulation of CD8+ T cell responses
CD8 T 细胞反应的树突状细胞调节
- 批准号:
7211374 - 财政年份:2005
- 资助金额:
$ 34.88万 - 项目类别:
IL-15 treatment of SIV-infected non-human primates
IL-15 治疗 SIV 感染的非人灵长类动物
- 批准号:
7149982 - 财政年份:2004
- 资助金额:
$ 34.88万 - 项目类别:
相似国自然基金
Long-TSLP和Short-TSLP佐剂对新冠重组蛋白疫苗免疫应答的影响与作用机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
Long-TSLP和Short-TSLP佐剂对新冠重组蛋白疫苗免疫应答的影响与作用机制
- 批准号:32170937
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
新疆一枝蒿多糖佐剂影响DCs调控Th1/Th2免疫应答的重要机制
- 批准号:31960164
- 批准年份:2019
- 资助金额:40 万元
- 项目类别:地区科学基金项目
草甘膦除草剂中佐剂对大豆根际土壤微生物群落的影响及其机制研究
- 批准号:31870495
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
亚细胞环境响应性的纳米材料与TLR激动剂复合制剂对疫苗免疫原性的影响
- 批准号:31600812
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Cellular mechanisms for the degeneration and aging of human rotator cuff tears
人类肩袖撕裂变性和衰老的细胞机制
- 批准号:
10648672 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
关节内药物递送调节炎症性关节疾病中的免疫细胞
- 批准号:
10856753 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
$ 34.88万 - 项目类别: